Global Health: Results for the Quarter and Half Year ended September 30, 2026
Global Health (MEDANTA) filed a disclosure titled "Results for the Quarter and Half Year ended September 30, 2026". The company is valued at about ₹34,910 crore.
What happened
Global Health (MEDANTA) filed a disclosure with the exchanges on 3 November 2026 at 04:11 PM titled "Results for the Quarter and Half Year ended September 30, 2026".
Company snapshot
Global Health is a mid-cap company in the Healthcare sector, with a market value of about ₹34,910 crore.
The stock last traded at ₹1,298.4, against a 52-week range of ₹956–₹1,544 (15.9% below the high).
Before this filing the shares had moved −4.9% over the month and −7.6% over three months. Average daily turnover over the last 20 sessions was about ₹25.84 crore.
Promoters held 33.00% at the end of Q1 FY27. Foreign institutions owned 9.46% and domestic institutions 16.89%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 1,031 | 159 | 5.92 |
| Q2 FY26 | 1,099 | 158.4 | 5.89 |
| Q3 FY26 | 1,121 | 95 | 3.54 |
| Q4 FY26 | 1,159 | 144 | 5.36 |
| Q1 FY27 | 1,304 | 158.7 | 5.91 |
What history shows
This is not the company's first results disclosure: BCEIE has 4 earlier filings of this kind on record since May 2026.
After those filings, the stock gained 2.0% on average the next trading day and was up 2.8% on average after five days (3 filings with price data).
Across 300 similar disclosures by other Healthcare companies, shares moved +1.3% on average the next day and +1.9% over five days; 57% of them rose the next day.
Market-wide, 10,321 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 30 Jul 2026 | A press release dated July 30, 2026, titled "Press release for the… | +2.0% | +2.8% |
| 30 Jul 2026 | Result For The Quarter Ended June 30, 2026 | +2.0% | +2.8% |
| 30 Jul 2026 | Board Meeting Outcome for Board Meeting Outcome For Intimation Under… | +2.0% | +2.8% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 3 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- World Conference on Traditional Medicine 2026 delivers landmark outcomes for global health
- Lancet: climate change should be treated as a global health emergency
- Income, not geography, drives global health coverage gaps: Study
- Call For New WHO Instrument To Address Climate-Driven Global Health Emergency
- Global Health Threats: 17 Risks Identified by 2100 | WEF
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.